Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer.

MLA

Zelefsky, M. J., et al. “Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer.” International Journal of Radiation Oncology, Biology, Physics, vol. 102, Nov. 2018, pp. S37–38. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2018.06.073.

APA

Zelefsky, M. J., Yamada, Y., Lis, E., Schoder, H., Lochansingh, S., Shi, W., Zhigang, Z., Braunstein, S. E., Kolesnick, R., & Fuks, Z. (2018). Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer. International Journal of Radiation Oncology, Biology, Physics, 102, S37–S38. https://doi.org/10.1016/j.ijrobp.2018.06.073

Chicago

Zelefsky, M.J., Y. Yamada, E. Lis, H. Schoder, S. Lochansingh, W. Shi, Z. Zhigang, S.E. Braunstein, R. Kolesnick, and Z. Fuks. 2018. “Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer.” International Journal of Radiation Oncology, Biology, Physics 102 (November): S37–38. doi:10.1016/j.ijrobp.2018.06.073.